{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidihgsrlwrgzecnjlq4xqorsccw5w2jxcvlhkecspiutgqsyjn44i",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnunrt5deim2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidlw5oxhi3owssg2o2g3n3fqsqo6odz6neugdb6wlkogg323egila"
    },
    "mimeType": "image/jpeg",
    "size": 209945
  },
  "path": "/news/2026-06-physicianresearcher-yields-landmark-year-crohn.html",
  "publishedAt": "2026-06-09T12:20:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A physician–scientist and national leader in inflammatory bowel disease at the University of Cincinnati has led the publication of landmark five-year efficacy and safety data for guselkumab, a biologic therapy for moderately to severely active Crohn's disease.",
  "title": "Physician–researcher's work yields landmark five-year data for Crohn's disease drug"
}